FDA Warns Against Overuse of TPOXX Monkeypox Drug
Agency says research in labs, animals, and people suggests that monkeypox could develop resistance to the antiviral in multiple ways
Twelfth Version of Living Guideline Issued for Drugs for COVID-19
New update strongly recommends against use of sotrovimab and casirivimab-imdevimab for patients with COVID-19
Full-Dose Anticoagulation Beneficial for Critically Ill With COVID-19
However, no significant difference seen in efficacy or safety outcomes for clopidogrel versus no antiplatelet therapy
Bedaquiline-Pretomanid-Linezolid Regimens Compared for XDR TB
Overall risk-benefit ratio seems to favor patients receiving linezolid at dose of 600 mg for 26 weeks
U.S. Monkeypox Cases Decline, but Health Officials Worry About Reaching Minorities
In response, White House has opened up new monkeypox vaccine equity pilot program, aimed at expanding vaccine access to communities of color
Pediatric Brain Abscess, Empyema Hospitalizations Peaked in March 2022
March 2022 peak in cases linked to Streptococcus species consistent with historical seasonal fluctuations seen since 2016
ACIP Recommends PCV15 for Children Younger Than 19 Years
PCV15 includes two serotypes in addition to those in the PCV13 vaccine, and is recommended according to PCV13 dosing and schedules
WHO Says Pandemic’s End May Be Near
About 11,000 people around the world died from COVID-19 during the week of Sept. 5 to 11, a drop of 22 percent from the previous week
COVID-19 Hospitalization Rates Higher in Unvaccinated During Omicron
Hospitalization rates 2.5 times higher for vaccinated patients without booster versus those with booster
Maternal Infection and Autism, Intellectual Disability Links Examined
Associations attenuated in sibling analysis indicating that the links were not causal
